Nutrition Intervention to Decrease Symptoms in Patients With Heart Failure
NCT01733017 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2017-03-17
Summary
The purpose of is to test the effects of a 6-month nutrition intervention of dietary sodium reduction combined with supplementation of lycopene and omega-3 fatty acids on heart failure symptoms, health-related quality of life, and time to heart failure rehospitalization or all-cause death.
Conditions
Interventions
- BEHAVIORAL
-
Sodium reduction
Teaching and skill building to reduce dietary sodium
- DIETARY_SUPPLEMENT
-
omega 3 and lycopene supplements
omega-3 fatty acid supplements and juices containing lycopene
- DIETARY_SUPPLEMENT
-
rice bran oil capsules
placebo capsules
- BEHAVIORAL
-
Generic dietary feedback from
Provided a summary of the 3 day dietary recalls at baseline, 3 months, and 6 months
Sponsors & Collaborators
-
Ohio State University
collaborator OTHER -
Terry Lennie
lead OTHER
Principal Investigators
-
Terry A Lennie, PhD · University of Kentucky College of Nursing
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-11-30
- Primary Completion
- 2017-01-31
- Completion
- 2017-01-31
Countries
- United States
Study Locations
More Related Trials
-
Evaluating the Relationship Between Fatty Acids and Heart Disease
NCT00404872 ·Status: COMPLETED
-
Polyunsaturates and KCL to Control Mild Hypertension
NCT00000511 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Effects of Omega-3 Fatty Acids on Heart Disease and Behavior
NCT00663871 ·Status: COMPLETED ·Phase: NA
-
The Effect of Omega-3 Polyunsaturated Fatty Acids in Congestive Heart Failure
NCT00944229 ·Status: TERMINATED ·Phase: PHASE3
-
Feasibility Study of Omega-3 Fatty Acids in Dialysis Patients
NCT01002118 ·Status: TERMINATED ·Phase: NA
-
Reversal of Right Ventricular Steatosis in Pulmonary Hypertension
NCT02966899 ·Status: WITHDRAWN ·Phase: NA
-
Effect of a Mediterranean Diet and Omega-3 Fatty Acids on Oxidative Stress and Endothelial Progenitor Cells (EPC's)
NCT00166088 ·Status: COMPLETED ·Phase: PHASE2
-
An Evaluation of Omega-3 Fatty Acid
NCT03017651 ·Status: COMPLETED ·Phase: PHASE1
-
Do Fish Oils Prevent Restenosis Post-Coronary Angioplasty?
NCT00000473 ·Status: COMPLETED ·Phase: PHASE3
-
Supplementation of Glutamine and Fish Oil Versus Placebo in Patients With Heart Failure
NCT01534663 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of omega3 on Congestive Heart Failure
NCT01227837 ·Status: COMPLETED ·Phase: NA
-
Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure
NCT00149409 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Cardiometabolic Benefits of Omega-3 Polyunsaturated Fatty Acids
NCT03378232 ·Status: COMPLETED ·Phase: NA
-
Antiarrhythmic Effects of N-3 Fatty Acids
NCT00004558 ·Status: COMPLETED ·Phase: PHASE2
-
Omega-3 Fatty Acids Supplementation and Atherothrombotic Biomarkers in Type 2 Diabetes and Cardiovascular Disease.
NCT02178501 ·Status: COMPLETED ·Phase: NA
-
Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
NCT03372733 ·Status: RECRUITING ·Phase: PHASE2
-
Omega 3 Fatty Acids and Atrial Fibrillation
NCT00508248 ·Status: WITHDRAWN ·Phase: NA
-
PUFAs and Left Ventricular Function in Heart Failure
NCT01223703 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Omega-3 Docosapentaenoic Acid on Lipids and Other Risk Factors for Cardiovascular Disease
NCT04088240 ·Status: TERMINATED ·Phase: NA
-
Omega-3D: Omega-3 for Diet-Driven Health Disparities
NCT07078344 ·Status: RECRUITING ·Phase: PHASE2
-
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
NCT00360217 ·Status: COMPLETED ·Phase: NA
-
Intervention With Omega Fatty Acids in High-risk Patients
NCT02647333 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation Into the Effects of Krill Oil vs. Fish Oil on Markers of Cardiovascular Disease
NCT01705678 ·Status: COMPLETED ·Phase: NA
-
Improving Metabolic Health in Patients With Diastolic Dysfunction
NCT03448185 ·Status: COMPLETED ·Phase: NA
-
Does Omega-3 Polyunsaturated Fatty Acids (PUFAs) Pretreatment Improve Outcomes in Patients Undergoing Percutaneous Coronary Intervention (PCI)?
NCT01723345 ·Status: UNKNOWN ·Phase: PHASE3